Information Provided By:
Fly News Breaks for January 4, 2016
EW
Jan 4, 2016 | 07:55 EDT
JPMorgan analyst Michael Weinstein calls Edwards Lifesciences a top pick for 2016 and reiterates an Overweight rating on the name with a $98 price target. The analyst views the PARTNER 2A data as a major catalyst for transcatheter replacement adoption and sees significant upside potential to consensus estimates.
News For EW From the Last 2 Days
There are no results for your query EW